Zobrazeno 1 - 10
of 1 051
pro vyhledávání: '"Kremsner, PG"'
Autor:
Adegbite, BR, Edoa, JR, Agbo Achimi Abdul, JBP, Epola, M, Mevyann, C, Dejon-Agobé, JC, Zinsou, JF, Honkpehedji, YJ, Mpagama, SG, Alabi, AS, Kremsner, PG, Klipstein-Grobusch, K, Adegnika, AA, Grobusch, MP
Publikováno v:
In eClinicalMedicine March 2022 45
Autor:
Krishna, S, Kremsner, PG
Publikováno v:
Malaria Journal. 21
We read with interest the publication on malaria treatment by Obonyo et al. (Malaria J 21:30, 2022). This commentary questions the methodology, especially the chosen time points of treatment outcome measures.
Autor:
Gabor, JJ, Kreidenweiss, A, Weber, S, Salama, M, Sulyok, M, Sulyok, Z, Koehne, E, Esen, M, Kreuels, B, Shamsrizi, P, Biecker, E, Mordmüller, B, Berg, CP, Fusco, S, Köhler, C, Kubicka, S, Leitlein, J, Addo, M, Ramharter, M, Schwab, M, Bissinger, AL, Velavan, TP, Krishna, S, Kremsner, PG
INTRODUCTION: Hydroxychloroquine use in COVID-19 patients was widespread and uncontrolled until recently. Patients vulnerable to severe COVID-19 are at risk for hydroxychloroquine interactions with comorbidities and co-medications contributing to det
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::e84823422d082327907887459195f4fb
https://openaccess.sgul.ac.uk/id/eprint/113192/1/PIIS1201971221003209.pdf
https://openaccess.sgul.ac.uk/id/eprint/113192/1/PIIS1201971221003209.pdf
Autor:
Adjuik, M, Agnamey, P, Babiker, A, Borrmann, S, Brasseur, P, Cisse, M, Cobelens, F, Diallo, S, Faucher, JF, Garner, P, Gikunda, S, Kremsner, PG, Krishna, S, Lell, B, Loolpapit, M, Matsiegui, P-B, Missinou, MA, Mwanza, J, Ntoumi, F, Olliaro, P, Osimbo, P, Rezbach, P, Some, E, Taylor, WRJ
Publikováno v:
In The Lancet 20 April 2002 359(9315):1365-1372
Autor:
Kremsner PG (AUTHOR), Krishna S (AUTHOR)
Publikováno v:
Lancet. 7/17/2004, Vol. 364 Issue 9430, p285-294. 10p.
Autor:
Kendjo, E, Agbenyega, T, Bojang, K, Newton, CR, Bouyou-Akotet, M, Pedross, F, Kombila, M, Helbok, R, Kremsner, PG
Publikováno v:
PLoS ONE
PLoS ONE, Vol 8, Iss 3, p e58686 (2013)
PLoS ONE, Vol 8, Iss 3, p e58686 (2013)
BACKGROUND: In this study we aimed to assess site heterogeneity of early, intermediate, and late mortality prediction in children with severe Plasmodium falciparum malaria in sub-Saharan Africa. METHODS: Medical records of 26,036 children admitted wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::c98acc391f299e475323df37e53741b7
https://doi.org/10.1371/journal.pone.0058686
https://doi.org/10.1371/journal.pone.0058686
Autor:
Sirima, SB, Mordmüller, B, Milligan, P, Ngoa, UA, Kironde, F, Atuguba, F, Tiono, AB, Issifou, S, Kaddumukasa, M, Bangre, O, Flach, C, Christiansen, M, Bang, P, Chilengi, R, Jepsen, S, Kremsner, PG, Theisen, M, GMZ2 Trial Study Group, COLLABORATORS, Ouédraogo, A, Kargougou, D, Nébié, I, Débé, S, Diarra, A, Bougouma, E, Hounkpatin, AB, Adegnika, AA, Lell, B, Joanny, F, Honkpehedji, YJ, Agobe, JC, Esen, M, Ajua, A, Asoala, V, Anyorigiya, T, Ansah, NA, Buwembo, W, Mworozi, E, Sekikubo, M, Abubakar, I, Bojang, K, Noor, R, Okech, B, Ejigu, DA
GMZ2 is a recombinant protein malaria vaccine, comprising two blood-stage antigens of Plasmodium falciparum, glutamate-rich protein and merozoite surface protein 3. We assessed efficacy of GMZ2 in children in Burkina Faso, Gabon, Ghana and Uganda. :
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::cef579ededdae68d48b9b10eb3e376b2
https://researchonline.lshtm.ac.uk/id/eprint/2699472/1/gmz2_trial.pdf
https://researchonline.lshtm.ac.uk/id/eprint/2699472/1/gmz2_trial.pdf
Autor:
Helbok, R, Kendjo, E, Issifou, S, Lackner, P, Newton, CR, Kombila, M, Agbenyega, T, Dietz, K, Bojang, K, Schmutzhard, E, Kremsner, PG
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::f19c5accd172dff86264acd2da1d2634
https://ora.ox.ac.uk/objects/uuid:10868d7d-e597-4e8b-937f-ec5a22c93dc2
https://ora.ox.ac.uk/objects/uuid:10868d7d-e597-4e8b-937f-ec5a22c93dc2
Autor:
Agnandji, ST, Lell, B, Fernandes, JF, Abossolo, BP, Kabwende, AL, Adegnika, AA, Mordmueller, B, Issifou, S, Kremsner, PG, Loembe, MM, Sacarlal, J, Aide, P, Madrid, L, Lanaspa, M, Mandjate, S, Aponte, JJ, Bulo, H, Nhama, A, Macete, E, Alonso, P, Abdulla, S, Salim, N, Mtoro, AT, Mutani, P, Tanner, M, Mavere, C, Mwangoka, G, Lweno, O, Juma, OA, Shekalaghe, S, Tinto, H, D'Alessandro, U, Sorgho, H, Valea, I, Ouedraogo, JB, Lompo, P, Diallo, S, Traore, O, Bassole, A, Dao, E, Hamel, MJ, Kariuki, S, Oneko, M, Odero, C, Otieno, K, Awino, N, Muturi-Kioi, V, Omoto, J, Laserson, KF, Slutsker, L, Otieno, W, Otieno, L, Otsyula, N, Gondi, S, Otieno, A, Ogutu, B, Ochola, J, Onyango, I, Oyieko, J, Njuguna, P, Chilengi, R, Akoo, P, Kerubo, C, Maingi, C, Olotu, A, Bejon, P, Marsh, K, Mwabingu, G, Gitaka, J, Owusu-Agyei, S, Asante, KP, Boahen, O, Dosoo, D, Adjei, G, Adeniji, E, Yawson, AK, Kayan, K, Chandramohan, D, Greenwood, B, Lusingu, J, Gesase, S, Malabeja, A, Abdul, O, Mahende, C, Liheluka, E, Lemnge, M, Theander, TG, Drakeley, C, Mbwana, J, Ansong, D, Agbenyega, T, Adjei, S, Boateng, HO, Rettig, T, Bawa, J, Sylverken, J, Sambian, D, Sarfo, A, Agyekum, A, Martinson, F, Hoffman, I, Mvalo, T, Kamthunzi, P, Nkomo, R, Tembo, T, Tsidya, GTM, Kilembe, J, Chawinga, C, Ballou, WR, Cohen, J, Guerra, Y, Jongert, E, Lapierre, D, Leach, A, Lievens, M, Ofori-Anyinam, O, Olivier, A, Vekemans, J, Kaslow, D, Leboulleux, D, Savarese, B, Schellenberg, D, Partnership, RTSSCT
Publikováno v:
PLoS Medicine
PLoS Medicine, Vol 11, Iss 7, p e1001685 (2014)
PLoS Medicine, Vol 11, Iss 7, p e1001685 (2014)
Mary Hamel and colleagues in the RTS,S Clinical Trials Partnership report updated safety and efficacy results from an ongoing Phase 3 trial, including calculations of vaccine impact (malaria cases prevented). Please see later in the article for the E
Autor:
Kremsner PG (AUTHOR)
Publikováno v:
Lancet. 4/23/2005, Vol. 365 Issue 9469, p1441-1443. 3p.